By specifically and precisely targeting key molecules in the pyroptosis pathway, such as NLRP3 and GSDMD, pathological processes of liver diseases can be alleviated without compromising the body’s immune defense mechanisms. The gene discussed is GSDMD; the disease is liver disorder.